India's drug controller grants approval to 1st intranasal COVID-19 vaccine-Xinhua
India's drug controller grants approval to 1st intranasal COVID-19 vaccine-
Stay updated with breaking news from Restricted Use. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India's drug controller grants approval to 1st intranasal COVID-19 vaccine-
Hyderabad based biotechnology company Bharat Biotech has launched the world's first nasal Covid-19 vaccine. According to a Tweet shared by Bharat Biotech, iNCOVACC recently received approval under Restricted Use in Emergency Situation for ages 18 and above for heterologous booster doses According to Bharat Biotech, iNCOVACC is a novel adenovirus vectored, intranasal vaccine for COVID-19.…
The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries, Bharat Biotech said.
Makers of the world’s first intranasal Covid 19 shot, Hyderabad-based Bharat Biotech, on Monday announced that the vaccine iNCOVACC (BBV154) had received approval from the Central Drugs Standard Control Organisation (CDSCO) under Restricted Use in Emergency Situation for ages 18 and above, in
Leading vaccine maker, Bharat Biotech International Limited (BBIL) on Monday announced that world's first intranasal vaccine for Covid-19, iNCOVACC (BBV154), has received approval from the Central Drugs Standard Control Organisation (CDSCO) ...